Hip Disease, Hip Dysplasia, Hip Fractures, Hip Injuries
Conditions
Brief summary
The study compares the effectiveness and safety of the pericapsular nerve blockade vs. ESPB in pediatric patients who underwent hip surgeries.
Detailed description
The study compares the effectiveness and safety of the pericapsular nerve blockade vs. ESPB in pediatric patients who underwent hip surgeries. In addition, we aim to determine the optimal volume of local anesthetics needed to achieve a satisfactory level of analgesia.
Interventions
DRUGPericapsular nerve group block using 0.2% ropivacaine
Unilateral ultrasound guided pericapsular nerve block using 0.5mL/kg 0.2% Ropimol (max 20mL)
Unilateral ultrasound guided erector spinae block using 0.5mL/kg 0.2% Ropimol (max 20mL)
OTHERStandard care
No erector spinae block and no pericapsular nerve group block
Sponsors
Poznan University of Medical Sciences
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)
Masking description
Patients will be randomly allocated to receive ultrasound-guided PENG block, ESP block, or only spinal anesthesia by computer software 1:1:1. A researcher who will not involve in the study will prepare the randomization list and concealed group assignments in consecutively numbered, sealed, opaque envelopes. A consultant anesthesiologist will follow management to open the envelopes shortly before the nerve block performance to reveal the group allocation and perform the procedure according to the assignment. The patients and their anesthesia team, surgeon, operating room staff, and parents will be masked to the study group allocation. Group blinding unmasking will only occur once the statistical analysis is complete.
Intervention model description
Three groups: Group I -control Group II - PENG block Group III - ESP block
Eligibility
Sex/Gender
ALL
Age
2 Months to 12 Years
Healthy volunteers
No
Inclusion criteria
\- pediatric patients aged between 0-12 years who will undergo hip surgery
Exclusion criteria
* a history of chronic pain use of gabapentin/pregabalin for \> 3 months opioid use \> 1 repeated opioid prescription in the last three months * morbid obesity (BMI \> 99th percentile) * Infection at block application area * coagulopathy
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| FLACC score | 48 hours after surgery | The FLACC scale or Face, Legs, Activity, Cry, Controllability Scale is used to assess pain for children between the ages of 2 months and seven years or individuals unable to communicate their pain. The scale is scored in a range of 0-10, with 0 representing no pain. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| PLR | 48 hours after surgery | platelet-to-lymphocyte ratio |
| total opioid consumption | 48 hours after surgery | morphine equivalents in miligrams |
| NLR | 48 hours after surgery | neutrophil-to-lymphocyte ratio |
Countries
Poland
Outcome results
None listed